Latest Development Activity News

Capstone Copper delivered a standout first quarter in 2025 with record sulphide copper output and adjusted EBITDA more than doubling year-over-year, underpinning its confidence in meeting full-year guidance and advancing key growth projects.

Discovery Alaska Limited has announced the termination of its mining lease for the Vinasale Project, choosing to preserve capital and concentrate on its flagship Chulitna Project alongside exploring new opportunities.

Elixir Energy has successfully closed its Share Purchase Plan, raising an additional $117,000 and bringing total capital raised to $7.1 million, supported by new shares and free attaching options.

Ark Mines Ltd has successfully raised A$1.5 million through a fully subscribed placement, enabling a faster development of its rare earth project in North Queensland.

Southern Cross Gold Consolidated Ltd has successfully arranged a C$143 million private placement, positioning the company to accelerate development of its Sunday Creek Gold-Antimony Project in Victoria, Australia.

MetalsTech Limited has made significant progress on its Sturec Gold Mine project in Slovakia, advancing the Pre-Feasibility Study and raising A$3.3 million to fund development and strengthen its balance sheet.

Horseshoe Metals Limited has reignited development at its Horseshoe Lights Copper-Gold Project, securing a $4 million convertible loan and entering a strategic agreement with Melody Gold to process gold surface materials, positioning the company for early cash flow and expanded exploration.

Macro Metals Limited has secured $2 million from a strategic placement to Paramount Earthmoving, advanced exploration across multiple Pilbara projects, and entered a second majority Indigenous-owned joint venture, positioning itself for growth in mining services.

PARKD Limited has secured a pivotal 5-year exclusive licence with Fielders for its metal deck support IP, completed a major car storage facility, and reported positive operating cash flow in Q3 FY25, positioning the company for expanded commercial growth.

8common Limited reported a record Q3 FY25 SaaS and transaction revenue of $1.1 million, alongside a 33% reduction in operational costs, supported by technology upgrades and a $1.5 million financing facility.

Recce Pharmaceuticals reports strong Phase II clinical trial results for its topical anti-infective R327G, achieving a 93% efficacy rate in treating ABSSSI, alongside a significant capital raise to fund upcoming Phase III trials.

Theta Gold Mines reports significant progress in funding discussions, plant construction, and resource integration for its TGME gold project in South Africa during Q1 2025.